Brainstorm Cell Therapeutics | BCLI - Des Atouts





Des Atouts Changement Date
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Biogen USD 29.48B 43.6M 2026-03
Brainstorm Cell Therapeutics USD 755K 267K 2026-03
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.27B 151.06M 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
Mesoblast USD 782.31M 2.38M 2025-12